Ex:Headache

Cancers: next NCT00512551 NCT00512551 DNA Array Analysis of Patients With Cervical Cancer Active, not recruiting .... Details .... Cervical Cancer NCT00352638 NCT00352638 Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer Completed .... Details .... Colorectal Cancer NCT01594398 NCT01594398 Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer Recruiting .... Details .... Lung Cancer .... Details .... Non Small Cell Lung Cancer NSCLC .... Details .... Breast Cancer .... Details .... ER+ Breast Cancer NCT00466960 NCT00466960 Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy Completed .... Details .... Brenner Tumor .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Clear Cell Cystadenocarcinoma .... Details .... Ovarian Endometrioid Adenocarcinoma .... Details .... Ovarian Mixed Epithelial Carcinoma .... Details .... Ovarian Mucinous Cystadenocarcinoma .... Details .... Ovarian Serous Cystadenocarcinoma .... Details .... Ovarian Undifferentiated Adenocarcinoma .... Details .... Peritoneal Cavity Cancer .... Details .... Recurrent Ovarian Epithelial Cancer .... Details .... Stage III Ovarian Epithelial Cancer .... Details .... Stage IV Ovarian Epithelial Cancer NCT00372840 NCT00372840 Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer Active, not recruiting .... Details .... Breast Cancer .... Details .... Colorectal Cancer .... Details .... Lung Cancer .... Details .... Malignant Mesothelioma .... Details .... Prostate Cancer .... Details .... Psychosocial Effects of Cancer and Its Treatment .... Details .... Thymoma and Thymic Carcinoma NCT00533884 NCT00533884 Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic Active, not recruiting .... Details .... Neurocognitive Impairment .... Details .... Delirium .... Details .... Esophageal Cancer .... Details .... Head and Neck Cancer .... Details .... Lung Cancer NCT00108745 NCT00108745 Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00666731 NCT00666731 A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer Recruiting .... Details .... Breast Cancer .... Details .... Precancerous Condition NCT01064349 NCT01064349 Breast Cancer With Over-expression of erbB2-BRAINSTORM Completed .... Details .... Cancer .... Details .... Breast Cancer NCT01259479 NCT01259479 Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors Recruiting .... Details .... Solid Tumors .... Details .... Brain Tumors .... Details .... Brain Metastases NCT01138124 NCT01138124 Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) Completed .... Details .... Renal Pelvis Cancer .... Details .... Restless Legs Syndrome .... Details .... Epilepsy .... Details .... Neuropathic Pain .... Details .... Chronic Pancreatitis .... Details .... Hypertension .... Details .... Pancreatic Cancer .... Details .... Diabetes .... Details .... Renal Cancer .... Details .... Renal Cell Carcinoma NCT00665899 NCT00665899 A Couples Approach to Enhance Breast Cancer Survivorship Completed .... Details .... Early-Stage Breast Cancer NCT00386217 NCT00386217 Psychosocial Impact of Cancer-Related Female Infertility Completed .... Details .... Hodgkin's Disease .... Details .... Cervical Cancer .... Details .... Breast Cancer .... Details .... Lymphoma NCT01460134 NCT01460134 A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers Recruiting .... Details .... CD27 Expressing B-cell Malignancies .... Details .... CD27 Expressing Solid Tumors .... Details .... Chronic Lymphocytic Leukemia .... Details .... Burkett's Lymphoma .... Details .... Mantle Cell Lymphoma .... Details .... Primary Lymphoma of the Central Nervous System .... Details .... Marginal Zone B Cell Lymphoma .... Details .... Solid Tumor .... Details .... Metastatic Melanoma .... Details .... Renal Clear Cell Carcinoma .... Details .... Hormone-refractory Prostate Adenocarcinoma .... Details .... Ovarian Cancer .... Details .... Colorectal Adenocarcinoma .... Details .... Non-small Cell Lung Cancer NCT00182767 NCT00182767 Ixabepilone and Liposomal Doxorubicin in Treating Women With Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer or Metastatic Breast Cancer Recruiting .... Details .... Breast Cancer .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT01118052 NCT01118052 EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00963092 NCT00963092 Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer Recruiting .... Details .... Adenocarcinoma of the Gastroesophageal Junction .... Details .... Esophageal Cancer .... Details .... Gastric Cancer NCT00389610 NCT00389610 Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Active, not recruiting .... Details .... Anorexia .... Details .... Fatigue .... Details .... Pain .... Details .... Pancreatic Cancer .... Details .... Psychosocial Effects of Cancer and Its Treatment NCT00483782 NCT00483782 Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00436501 NCT00436501 VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00777192 NCT00777192 Longitudinal Study of Symptoms in Colorectal Cancer Recruiting .... Details .... Colorectal Cancer NCT00478010 NCT00478010 Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer Active, not recruiting .... Details .... Colorectal Cancer .... Details .... Pancreatic Cancer .... Details .... Psychosocial Effects of Cancer and Its Treatment NCT00918892 NCT00918892 Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Breast Cancer Recruiting .... Details .... Breast Cancer NCT00039091 NCT00039091 Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer Active, not recruiting .... Details .... Leukemia .... Details .... Lung Cancer .... Details .... Melanoma Skin .... Details .... Myelodysplastic Syndromes .... Details .... Myelodysplastic Myeloproliferative Neoplasms .... Details .... Ovarian Cancer NCT01445275 NCT01445275 Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199 Not yet recruiting .... Details .... Fallopian Tube Cancer .... Details .... Hereditary Breast Ovarian Cancer brca1, brca2 .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00633750 NCT00633750 Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery Completed .... Details .... Breast Cancer NCT01480154 NCT01480154 Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors or Prostate or Kidney Cancer Recruiting .... Details .... Kidney Cancer .... Details .... Prostate Cancer .... Details .... Unspecified Adult Solid Tumor, Protocol Specific NCT01254591 NCT01254591 Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer Recruiting .... Details .... Breast Cancer .... Details .... Colorectal Cancer .... Details .... Esophageal Cancer .... Details .... Head and Neck Cancer .... Details .... Lung Cancer NCT00899093 NCT00899093 Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT01149434 NCT01149434 Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers Active, not recruiting .... Details .... Cancer .... Details .... Neuroendocrine .... Details .... Ovarian Cancer .... Details .... Colon Cancer NCT01074411 NCT01074411 Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00387465 NCT00387465 Azacitidine and MS-275 in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer Suspended .... Details .... Lung Cancer NCT01236053 NCT01236053 Cancer in Patients With Gabapentin (GPRD) Completed .... Details .... Pain, Neuropathic .... Details .... Epilepsy .... Details .... Renal Pelvis Cancer .... Details .... Pancreatic Cancer .... Details .... Breast Cancer .... Details .... Nervous System Cancer .... Details .... Chronic Pancreatitis .... Details .... Stomach Cancer .... Details .... Renal Cell Carcinoma .... Details .... Diabetes .... Details .... Bladder Cancer .... Details .... Bone and Joint Cancer .... Details .... Penis Cancer .... Details .... Anal Cancer .... Details .... Cancer .... Details .... Renal Cancer NCT01174121 NCT01174121 A Phase II Study Using Short-Term Cultured, CD8+-Enriched Autologous Tumor-infiltrating Lymphocytes Following a Lymphocyte Depleting Regimen in Metastatic Digestive Tract Cancers Recruiting .... Details .... Metastatic Colorectal Cancer .... Details .... Metastatic Gastric Cancer .... Details .... Metastatic Pancreatic Cancer .... Details .... Metastatic Hepatocellular Carcinoma .... Details .... Metastatic Cholangiocarcinoma NCT01145430 NCT01145430 Veliparib and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer Not yet recruiting .... Details .... Breast Cancer .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00041080 NCT00041080 Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Completed .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00313612 NCT00313612 Oxaliplatin and Topotecan in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Completed .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00004087 NCT00004087 Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer Completed .... Details .... Colorectal Cancer .... Details .... Pancreatic Cancer NCT00480025 NCT00480025 GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer Active, not recruiting .... Details .... Tumor Antigen-positive Non-Small Cell Lung Cancer .... Details .... Lung Cancer, Non-Small Cell NCT00399529 NCT00399529 Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer Completed .... Details .... Breast Neoplasms NCT00085566 NCT00085566 Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer Active, not recruiting .... Details .... Brain and Central Nervous System Tumors .... Details .... Prostate Cancer NCT00084383 NCT00084383 Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas Completed .... Details .... Pancreatic Cancer NCT00903591 NCT00903591 Study of Radiation Exposure and Bilateral Breast Cancer Recruiting .... Details .... Breast Cancer NCT01571024 NCT01571024 BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohorts in KRAS Wild Type Metastatic Colorectal and Pancreatic Cancer Not yet recruiting .... Details .... Advanced Solid Tumors .... Details .... Metastatic Colorectal Cancer .... Details .... Metastatic Pancreatic Cancer NCT00652899 NCT00652899 Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer Terminated .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00565851 NCT00565851 Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Malignant Tumor of Peritoneum NCT00656123 NCT00656123 Vaccine Therapy and Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Liver Metastases Due to Colorectal Cancer Recruiting .... Details .... Colorectal Cancer .... Details .... Metastatic Cancer NCT01438554 NCT01438554 Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients With Advanced Differentiated Thyroid Cancer Recruiting .... Details .... Solid Tumors .... Details .... Advanced Thyroid Cancer NCT00803569 NCT00803569 Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer Completed .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00735514 NCT00735514 Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer Completed .... Details .... Cervical Cancer .... Details .... Endometrial Cancer .... Details .... Radiation Toxicity .... Details .... Sexuality and Reproductive Issues NCT00897468 NCT00897468 Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer Recruiting .... Details .... Breast Cancer NCT01372787 NCT01372787 Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer Recruiting .... Details .... Anxiety Disorder .... Details .... Fallopian Tube Cancer .... Details .... Fatigue .... Details .... Nausea and Vomiting .... Details .... Neurotoxicity .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00869739 NCT00869739 Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer Recruiting .... Details .... Cancer Survivor .... Details .... Depression .... Details .... Gastrointestinal Complications .... Details .... Male Erectile Disorder .... Details .... Prostate Cancer .... Details .... Psychosocial Effects of Cancer and Its Treatment .... Details .... Urinary Complications NCT00020787 NCT00020787 Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer Completed .... Details .... Esophageal Cancer .... Details .... Gastric Cancer NCT00693836 NCT00693836 Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region Recruiting .... Details .... Lung Cancer NCT01241721 NCT01241721 Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer Recruiting .... Details .... Breast Cancer .... Details .... Breast Cancer Surgery NCT01091428 NCT01091428 MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer Recruiting .... Details .... Ovarian Carcinoma .... Details .... Fallopian Tube Cancer .... Details .... Peritoneal Cancer .... Details .... Breast Carcinoma NCT00526851 NCT00526851 Oral Cancer Screening Among Nursing Home Dentists in Ohio Completed .... Details .... Head and Neck Cancer NCT00253500 NCT00253500 Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer Active, not recruiting .... Details .... Breast Cancer NCT00483639 NCT00483639 Study of Anxiety and Avoidance of Others in Patients Previously Treated for Head and Neck Cancer Active, not recruiting .... Details .... Anxiety Disorder .... Details .... Head and Neck Cancer .... Details .... Lung Cancer NCT01445418 NCT01445418 AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer Recruiting .... Details .... Breast Cancer .... Details .... Ovarian Cancer NCT00835679 NCT00835679 Cetuximab and/or Dasatinib in Treating Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery Recruiting .... Details .... Colorectal Cancer .... Details .... Metastatic Cancer NCT00948337 NCT00948337 A Study With Health Educational Material on Health Promotion in Cancer Survivors Active, not recruiting .... Details .... Stomach Cancer .... Details .... Colon Cancer .... Details .... Thyroid Cancer .... Details .... Breast Cancer NCT01465451 NCT01465451 Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety Recruiting .... Details .... Colorectal Cancer NCT00966667 NCT00966667 Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer Recruiting .... Details .... Colorectal Cancer NCT00757614 NCT00757614 Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Recruiting .... Details .... Bladder Cancer .... Details .... Brain and Central Nervous System Tumors .... Details .... Esophageal Cancer .... Details .... Intraocular Melanoma .... Details .... Kidney Cancer .... Details .... Lymphoma .... Details .... Melanoma Skin .... Details .... Pancreatic Cancer .... Details .... Transitional Cell Cancer of the Renal Pelvis and Ureter NCT01086696 NCT01086696 A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers Not yet recruiting .... Details .... Breast Cancer .... Details .... Lung Cancer .... Details .... Renal Cancer .... Details .... Adrenal Cancer NCT00869206 NCT00869206 Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Active, not recruiting .... Details .... Breast Cancer .... Details .... Metastatic Cancer .... Details .... Multiple Myeloma and Plasma Cell Neoplasm .... Details .... Musculoskeletal Complications .... Details .... Pain .... Details .... Prostate Cancer .... Details .... Urinary Complications NCT00900094 NCT00900094 UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer Completed .... Details .... Breast Cancer .... Details .... Colorectal Cancer .... Details .... Esophageal Cancer .... Details .... Liver Cancer .... Details .... Lung Cancer .... Details .... Ovarian Cancer .... Details .... Pancreatic Cancer NCT01598584 NCT01598584 Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer Not yet recruiting .... Details .... Pancreatic Cancer NCT00021034 NCT00021034 Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT01081262 NCT01081262 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer NCT00031681 NCT00031681 UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple-Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) Completed .... Details .... Cancer NCT01074398 NCT01074398 Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182 Not yet recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00974610 NCT00974610 Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer Recruiting .... Details .... Breast Cancer .... Details .... Colorectal Cancer .... Details .... Lung Cancer .... Details .... Melanoma Skin .... Details .... Pancreatic Cancer NCT01134172 NCT01134172 Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life Recruiting .... Details .... Breast Cancer NCT00522301 NCT00522301 Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission Completed .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT01295658 NCT01295658 Cancer Survivor Registry: The Breast Cancer M.A.P. (Mind Affects the Physical) Project Recruiting .... Details .... Breast Cancer NCT00458809 NCT00458809 Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer Completed .... Details .... Carcinoma of the Appendix .... Details .... Colorectal Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00662103 NCT00662103 Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer Survivors Active, not recruiting .... Details .... Breast Cancer .... Details .... Cancer Survivor .... Details .... Fatigue .... Details .... Long-term Effects Secondary to Cancer Therapy in Adults .... Details .... Psychosocial Effects of Cancer and Its Treatment NCT00499512 NCT00499512 Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer Active, not recruiting .... Details .... Ovarian Cancer .... Details .... Peritoneal Cancer .... Details .... Fallopian Tube Cancer NCT00510796 NCT00510796 Combined Colon and Endometrial Cancer Screening in Women With HNPCC Active, not recruiting .... Details .... Colon Cancer NCT00857545 NCT00857545 OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT01065441 NCT01065441 Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer Withdrawn .... Details .... Solid Tumors Stage II, Stage III and Stage IV .... Details .... Breast Cancer .... Details .... Colorectal Cancer .... Details .... Prostate Cancer .... Details .... Melanoma .... Details .... Ovarian Cancer .... Details .... Sarcoma .... Details .... Non-small Cell Lung Cancer NCT00499252 NCT00499252 Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Completed .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT01012609 NCT01012609 External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Recruiting .... Details .... Brain Cancer NCT00096395 NCT00096395 Sorafenib and Gemcitabine in Treating Patients With Recurrent or Refractory Ovarian Cancer or Primary Peritoneal Cancer Active, not recruiting .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT01434303 NCT01434303 Entinostat and Lapatinib Ditosylate in Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Recruiting .... Details .... Breast Cancer NCT00365105 NCT00365105 Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer Active, not recruiting .... Details .... Breast Cancer .... Details .... Lung Cancer .... Details .... Neoplasm Metastasis .... Details .... Pain .... Details .... Prostate Cancer NCT00604994 NCT00604994 Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer Active, not recruiting .... Details .... Female Genital Diseases .... Details .... Ovarian Cancer .... Details .... Cervical Cancer .... Details .... Endometrial Cancer .... Details .... Vulval Cancer NCT00373152 NCT00373152 MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer Withdrawn .... Details .... Breast Cancer NCT00582062 NCT00582062 Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples Active, not recruiting .... Details .... Gastric and Pancreatic Cancer NCT00903630 NCT00903630 Lenalidomide and Doxorubicin Hydrochloride Liposome in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Suspended .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00898378 NCT00898378 Study of Biomarkers Using Blood and Tissue Samples From Patients With Colorectal Cancer or Colorectal Polyps and From Patients Without Polyps Recruiting .... Details .... Colorectal Cancer .... Details .... Healthy, no Evidence of Disease .... Details .... Precancerous Condition NCT00301756 NCT00301756 PXD101 in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00182728 NCT00182728 Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer Active, not recruiting .... Details .... Breast Cancer NCT00008138 NCT00008138 S0009 Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Completed .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00028743 NCT00028743 Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00397904 NCT00397904 Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin Completed .... Details .... Esophageal Cancer .... Details .... Gastric Cancer NCT00580476 NCT00580476 Assessing Depression in a Geriatric Cancer Population Active, not recruiting .... Details .... Breast Cancer .... Details .... Prostate Cancer NCT01469429 NCT01469429 Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. Recruiting .... Details .... Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma .... Details .... Salivary Gland Squamous Cell Carcinoma .... Details .... Stage 0 Hypopharyngeal Cancer .... Details .... Stage 0 Laryngeal Cancer .... Details .... Stage 0 Lip and Oral Cavity Cancer .... Details .... Stage 0 Nasopharyngeal Cancer .... Details .... Stage 0 Oropharyngeal Cancer .... Details .... Stage 0 Paranasal Sinus and Nasal Cavity Cancer .... Details .... Stage I Salivary Gland Cancer .... Details .... Stage I Squamous Cell Carcinoma of the Hypopharynx .... Details .... Stage I Squamous Cell Carcinoma of the Larynx .... Details .... Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity .... Details .... Stage I Squamous Cell Carcinoma of the Nasopharynx .... Details .... Stage I Squamous Cell Carcinoma of the Oropharynx .... Details .... Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity .... Details .... Stage I Verrucous Carcinoma of the Larynx .... Details .... Stage I Verrucous Carcinoma of the Oral Cavity .... Details .... Stage II Salivary Gland Cancer .... Details .... Stage II Squamous Cell Carcinoma of the Hypopharynx .... Details .... Stage II Squamous Cell Carcinoma of the Larynx .... Details .... Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity .... Details .... Stage II Squamous Cell Carcinoma of the Nasopharynx .... Details .... Stage II Squamous Cell Carcinoma of the Oropharynx .... Details .... Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity .... Details .... Stage II Verrucous Carcinoma of the Larynx .... Details .... Stage II Verrucous Carcinoma of the Oral Cavity .... Details .... Stage III Salivary Gland Cancer .... Details .... Stage III Squamous Cell Carcinoma of the Hypopharynx .... Details .... Stage III Squamous Cell Carcinoma of the Larynx .... Details .... Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity .... Details .... Stage III Squamous Cell Carcinoma of the Nasopharynx .... Details .... Stage III Squamous Cell Carcinoma of the Oropharynx .... Details .... Stage III Verrucous Carcinoma of the Larynx .... Details .... Stage III Verrucous Carcinoma of the Oral Cavity .... Details .... Stage IV Squamous Cell Carcinoma of the Hypopharynx .... Details .... Stage IV Squamous Cell Carcinoma of the Nasopharynx .... Details .... Stage IVA Salivary Gland Cancer .... Details .... Stage IVA Squamous Cell Carcinoma of the Larynx .... Details .... Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity .... Details .... Stage IVA Squamous Cell Carcinoma of the Oropharynx .... Details .... Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity .... Details .... Stage IVA Verrucous Carcinoma of the Larynx .... Details .... Stage IVA Verrucous Carcinoma of the Oral Cavity .... Details .... Stage IVB Salivary Gland Cancer .... Details .... Stage IVB Squamous Cell Carcinoma of the Larynx .... Details .... Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity .... Details .... Stage IVB Squamous Cell Carcinoma of the Oropharynx .... Details .... Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity .... Details .... Stage IVB Verrucous Carcinoma of the Larynx .... Details .... Stage IVB Verrucous Carcinoma of the Oral Cavity .... Details .... Stage IVC Salivary Gland Cancer .... Details .... Stage IVC Squamous Cell Carcinoma of the Larynx .... Details .... Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity .... Details .... Stage IVC Squamous Cell Carcinoma of the Oropharynx .... Details .... Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity .... Details .... Stage IVC Verrucous Carcinoma of the Larynx .... Details .... Stage IVC Verrucous Carcinoma of the Oral Cavity .... Details .... Tongue Cancer NCT00087360 NCT00087360 Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants Completed .... Details .... Colorectal Cancer NCT00574951 NCT00574951 AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00899002 NCT00899002 Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer Completed .... Details .... Liver Cancer NCT00897338 NCT00897338 Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer Recruiting .... Details .... Breast Cancer NCT00847171 NCT00847171 Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer Recruiting .... Details .... Breast Cancer NCT01060514 NCT01060514 Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer Recruiting .... Details .... Metastatic Non Small Cell Lung Cancer .... Details .... Metastatic Breast Cancer NCT00971737 NCT00971737 Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer Recruiting .... Details .... Breast Cancer NCT00118300 NCT00118300 Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer Withdrawn .... Details .... Cervical Cancer .... Details .... Endometrial Cancer .... Details .... Ovarian Cancer .... Details .... Vaginal Cancer NCT00796874 NCT00796874 Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance Suspended .... Details .... Prostate Cancer NCT00821964 NCT00821964 Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer Recruiting .... Details .... Male Breast Cancer .... Details .... Recurrent Breast Cancer .... Details .... Skin Metastases .... Details .... Stage IV Breast Cancer NCT00004142 NCT00004142 Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver Completed .... Details .... Colorectal Cancer .... Details .... Metastatic Cancer NCT00945061 NCT00945061 Radiation Therapy in Treating Patients With Recurrent Breast Cancer Suspended .... Details .... Breast Cancer NCT00293293 NCT00293293 Hypnosis, Massage Therapy, and Healing Touch in Treating Patients Receiving Chemotherapy for Ovarian Epithelial Cancer or Peritoneal Cavity Cancer Completed .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00471536 NCT00471536 Pazopanib in Treating Patients With Metastatic Urothelial Cancer Completed .... Details .... Bladder Cancer .... Details .... Transitional Cell Cancer of the Renal Pelvis and Ureter .... Details .... Urethral Cancer NCT00376909 NCT00376909 A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women Active, not recruiting .... Details .... Breast Cancer .... Details .... Cervical Cancer .... Details .... Colorectal Cancer NCT00453661 NCT00453661 Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities Active, not recruiting .... Details .... Breast Cancer .... Details .... Cervical Cancer .... Details .... Prostate Cancer .... Details .... Colorectal Cancer .... Details .... Lung Cancer NCT00582387 NCT00582387 Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer Active, not recruiting .... Details .... Bladder Cancer .... Details .... Urinary Cancer .... Details .... Nonmuscle Invasive Bladder Cancer NCT00861107 NCT00861107 In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation Completed .... Details .... Metastatic Cancer NCT00888615 NCT00888615 Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Suspended .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00607607 NCT00607607 A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer Completed .... Details .... Ovarian Cancer .... Details .... Endometrial Cancer NCT00909441 NCT00909441 Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer Recruiting .... Details .... Breast Cancer .... Details .... Invasive Breast Cancer NCT00514215 NCT00514215 Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer Active, not recruiting .... Details .... Kidney Cancer .... Details .... Lung Cancer .... Details .... Metastatic Cancer .... Details .... Unspecified Adult Solid Tumor, Protocol Specific NCT00959023 NCT00959023 Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer Recruiting .... Details .... Prostate Cancer NCT01585428 NCT01585428 A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose Adesleukin for Human Papillomavirus-Associated Cancers Recruiting .... Details .... Cervical Cancer .... Details .... Oropharyngeal Cancer .... Details .... Vaginal Cancer .... Details .... Anal Cancer .... Details .... Penile Cancer NCT01498289 NCT01498289 Combination Chemotherapy in Treating Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer Recruiting .... Details .... Adenocarcinoma of the Gastroesophageal Junction .... Details .... Esophageal Cancer .... Details .... Gastric Cancer NCT00941759 NCT00941759 Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer Recruiting .... Details .... Breast Cancer NCT01385436 NCT01385436 Distribution of Human Papillomavirus (HPV) Genotypes in Patients With Cervical Cancer From Croatia Recruiting .... Details .... Cervical Cancer NCT00897208 NCT00897208 Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer Active, not recruiting .... Details .... Breast Cancer NCT00003926 NCT00003926 Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors Terminated .... Details .... Brain and Central Nervous System Tumors .... Details .... Childhood Germ Cell Tumor .... Details .... Chordoma .... Details .... Kidney Cancer .... Details .... Liver Cancer .... Details .... Neuroblastoma .... Details .... Ovarian Cancer .... Details .... Retinoblastoma .... Details .... Sarcoma NCT01229111 NCT01229111 Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers Recruiting .... Details .... Extrahepatic Bile Duct Cancer .... Details .... Gallbladder Cancer .... Details .... Liver Cancer .... Details .... Periampullary Adenocarcinoma NCT01335152 NCT01335152 Online Stress Management and Coping Skills Training for Women With Breast Cancer Active, not recruiting .... Details .... Breast Cancer NCT00019006 NCT00019006 Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer Completed .... Details .... Recurrent Colon Cancer .... Details .... Extensive Stage Small Cell Lung Cancer .... Details .... Stage III Pancreatic Cancer .... Details .... Stage III Rectal Cancer .... Details .... Limited Stage Small Cell Lung Cancer .... Details .... Recurrent Pancreatic Cancer .... Details .... Recurrent Rectal Cancer .... Details .... Stage III Non-Small Cell Lung Cancer .... Details .... Stage I Pancreatic Cancer .... Details .... Stage II Non-Small Cell Lung Cancer .... Details .... Stage IVB Pancreatic Cancer .... Details .... Stage II Pancreatic Cancer .... Details .... Stage III Colon Cancer .... Details .... Stage IVA Pancreatic Cancer NCT00041028 NCT00041028 EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Active, not recruiting .... Details .... Lung Cancer NCT00958698 NCT00958698 Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer .... Details .... Psychosocial Effects of Cancer and Its Treatment NCT00319748 NCT00319748 Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers Completed .... Details .... Breast Cancer .... Details .... Ovarian Cancer .... Details .... Endometrial Cancer .... Details .... Cervical Cancer NCT00586937 NCT00586937 Quality of Life in Lung Cancer Survivors Active, not recruiting .... Details .... Lung Cancer Survivors NCT01482715 NCT01482715 A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor Recruiting .... Details .... Metastatic Solid Tumor .... Details .... Breast Cancer .... Details .... Ovarian Cancer NCT00070252 NCT00070252 Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer Completed .... Details .... Breast Cancer .... Details .... Unspecified Adult Solid Tumor, Protocol Specific NCT00548236 NCT00548236 The Active After Cancer Trial (AACT) Active, not recruiting .... Details .... Breast Cancer .... Details .... Colorectal Cancer NCT00138242 NCT00138242 Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Completed .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00003064 NCT00003064 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT01489371 NCT01489371 EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Not yet recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00169845 NCT00169845 Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients Active, not recruiting .... Details .... Neoplasms NCT00902590 NCT00902590 Familial and Atypical Urothelial Cancer Registry Recruiting .... Details .... Urothelial Cancer .... Details .... Renal Pelvis Cancer .... Details .... Ureter Cancer .... Details .... Bladder Cancer NCT00450424 NCT00450424 Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer Recruiting .... Details .... Colorectal Cancer .... Details .... Hereditary Non-polyposis Colon Cancer NCT01220128 NCT01220128 Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer Recruiting .... Details .... Neoplasms, Breast .... Details .... WT1-positive Primary Invasive Breast Cancer NCT00897832 NCT00897832 Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer Active, not recruiting .... Details .... Pancreatic Cancer NCT00996710 NCT00996710 Genomic Structural Variation in Cancer Susceptibility Enrolling by invitation .... Details .... Breast Cancer .... Details .... Colon Cancer .... Details .... Germ Cell Cancer .... Details .... Neuroblastoma .... Details .... Rectal Cancer .... Details .... Sarcoma NCT01027221 NCT01027221 Low Dose Radiation to Improve T-Cell Infiltration in Pancreatic Cancer Recruiting .... Details .... Primarily Resectable Pancreatic Cancer NCT00516256 NCT00516256 CHESS: Human and Computer Mentors for Prostate Cancer Patients Active, not recruiting .... Details .... Prostate Cancer NCT00004604 NCT00004604 Biological Therapy in Treating Patients With Metastatic Cancer Active, not recruiting .... Details .... Breast Cancer .... Details .... Colorectal Cancer .... Details .... Extrahepatic Bile Duct Cancer .... Details .... Gallbladder Cancer .... Details .... Gastric Cancer .... Details .... Head and Neck Cancer .... Details .... Liver Cancer .... Details .... Lung Cancer .... Details .... Metastatic Cancer .... Details .... Ovarian Cancer .... Details .... Pancreatic Cancer .... Details .... Testicular Germ Cell Tumor NCT00507351 NCT00507351 Ambulatory Cancer Pain Management: A Feasibility Study Completed .... Details .... Breast Cancer .... Details .... Colorectal Cancer .... Details .... Lung Cancer .... Details .... Prostate Cancer NCT00616941 NCT00616941 A Phase I Study of NY-ESO-1 Overlapping Peptides (OLP4) Immunoadjuvants Montanide and Poly-ICLC Vaccination of Epithelial Ovarian Cancer (EOC), Fallopian Tube, or Primary Peritoneal Cancer Patients in Second or Third Remission Completed .... Details .... Epithelial Ovarian Cancer .... Details .... Fallopian Tube Cancer .... Details .... Primary Peritoneal Cancer NCT00217581 NCT00217581 Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer Active, not recruiting .... Details .... Esophageal Cancer .... Details .... Gastric Cancer NCT00005599 NCT00005599 Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer Completed .... Details .... Esophageal Cancer .... Details .... Gastric Cancer NCT01503229 NCT01503229 Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Not yet recruiting .... Details .... Adenocarcinoma of the Prostate .... Details .... Hormone-resistant Prostate Cancer .... Details .... Recurrent Prostate Cancer .... Details .... Stage IV Prostate Cancer NCT00751660 NCT00751660 Screening Methods in Finding Lung Cancer Early in Current or Former Smokers Active, not recruiting .... Details .... Lung Cancer .... Details .... Tobacco Use Disorder NCT00263822 NCT00263822 Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00107445 NCT00107445 EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer Completed .... Details .... Cervical Cancer .... Details .... Endometrial Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT00625846 NCT00625846 Pazopanib in Treating Patients With Advanced Thyroid Cancer Recruiting .... Details .... Head and Neck Cancer NCT00385866 NCT00385866 Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries Recruiting .... Details .... Cancer NCT00016289 NCT00016289 Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Completed .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT01276899 NCT01276899 Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients Recruiting .... Details .... Triple Negative Breast Cancer NCT01403103 NCT01403103 Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer Recruiting .... Details .... Mucinous Adenocarcinoma of the Colon .... Details .... Mucinous Adenocarcinoma of the Rectum .... Details .... Signet Ring Adenocarcinoma of the Colon .... Details .... Signet Ring Adenocarcinoma of the Rectum .... Details .... Stage I Colon Cancer .... Details .... Stage I Rectal Cancer NCT00357448 NCT00357448 Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Clear Cell Cystadenocarcinoma .... Details .... Ovarian Endometrioid Adenocarcinoma .... Details .... Ovarian Mixed Epithelial Carcinoma .... Details .... Ovarian Mucinous Cystadenocarcinoma .... Details .... Ovarian Serous Cystadenocarcinoma .... Details .... Ovarian Undifferentiated Adenocarcinoma .... Details .... Peritoneal Cavity Cancer .... Details .... Recurrent Ovarian Epithelial Cancer .... Details .... Stage III Ovarian Epithelial Cancer .... Details .... Stage IV Ovarian Epithelial Cancer NCT00085293 NCT00085293 Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 Active, not recruiting .... Details .... Head and Neck Cancer NCT00004065 NCT00004065 Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer Completed .... Details .... Bladder Cancer .... Details .... Breast Cancer .... Details .... Colorectal Cancer .... Details .... Gastric Cancer .... Details .... Head and Neck Cancer .... Details .... Kidney Cancer .... Details .... Leukemia .... Details .... Lung Cancer .... Details .... Melanoma Skin .... Details .... Ovarian Cancer .... Details .... Prostate Cancer .... Details .... Unspecified Adult Solid Tumor, Protocol Specific NCT00248911 NCT00248911 The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers Active, not recruiting .... Details .... Breast Cancers .... Details .... Gynecologic Cancer NCT00028912 NCT00028912 Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Completed .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Primary Peritoneal Cavity Cancer NCT01104129 NCT01104129 Stool Testing for Pancreatic Cancer Recruiting .... Details .... Pancreatic Cancer NCT01118975 NCT01118975 Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers Recruiting .... Details .... Breast Cancer .... Details .... Neoplasm Metastasis NCT00029224 NCT00029224 Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions Completed .... Details .... Breast Cancer .... Details .... Multiple Myeloma .... Details .... Prostate Cancer NCT00581646 NCT00581646 Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance Active, not recruiting .... Details .... Cervical Cancer .... Details .... Endometrial Cancer .... Details .... Leukemia .... Details .... Non-Hodgkin's Lymphoma .... Details .... Uterine Cancer .... Details .... Vaginal Cancer .... Details .... Infertility NCT00354601 NCT00354601 Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer Terminated .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00098917 NCT00098917 Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer Terminated .... Details .... Lung Cancer NCT00673335 NCT00673335 Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation Recruiting .... Details .... brca1 Mutation Carrier .... Details .... brca2 Mutation Carrier .... Details .... Breast Cancer .... Details .... Hereditary Breast Ovarian Cancer brca1, brca2 NCT00791037 NCT00791037 Vaccine Therapy in Treating Patients With Stage IV Breast Cancer Recruiting .... Details .... HER2-positive Breast Cancer .... Details .... Male Breast Cancer .... Details .... Recurrent Breast Cancer .... Details .... Stage IV Breast Cancer NCT00353483 NCT00353483 Effect of Chemotherapy Administered Before Surgery on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells Recruiting .... Details .... Breast Neoplasms NCT00268918 NCT00268918 Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients Active, not recruiting .... Details .... Ovarian Cancer .... Details .... Endometrial Cancer .... Details .... Cervical Cancer .... Details .... Fallopian Tube Cancer .... Details .... Peritoneal Cancer .... Details .... Breast Cancer NCT00125021 NCT00125021 Tarceva and Capecitabine for Pancreatic Cancer Completed .... Details .... Pancreatic Cancer .... Details .... Neoplasm Metastasis NCT00712569 NCT00712569 Physician-Patient Communication About Breast Cancer-Related Internet Information and Its Effect on Patient Satisfaction and Anxiety Active, not recruiting .... Details .... Breast Cancer NCT01292733 NCT01292733 Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer Recruiting .... Details .... Ovarian Diseases .... Details .... Ovarian Neoplasms NCT00275028 NCT00275028 AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer Active, not recruiting .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00813878 NCT00813878 Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease Active, not recruiting .... Details .... Breast Cancer NCT01299623 NCT01299623 Breast Cancer Prevention Education Recruiting .... Details .... Breast Cancer Prevention NCT01457131 NCT01457131 Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer Suspended .... Details .... Metastatic Cancer .... Details .... Metastatic Melanoma .... Details .... Metastatic Renal Cancer NCT00900133 NCT00900133 Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer Completed .... Details .... Breast Cancer NCT00019084 NCT00019084 Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer Completed .... Details .... Breast Cancer .... Details .... Cervical Cancer .... Details .... Colorectal Cancer .... Details .... Lung Cancer .... Details .... Ovarian Cancer .... Details .... Pancreatic Cancer NCT00602329 NCT00602329 MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer Recruiting .... Details .... Colorectal Cancer NCT00004136 NCT00004136 Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer Completed .... Details .... Liver Cancer .... Details .... Metastatic Cancer NCT01447186 NCT01447186 Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men Not yet recruiting .... Details .... Prostate Cancer .... Details .... Cancer NCT01322802 NCT01322802 Vaccine Therapy in Treating Patients With Stage III-IV Ovarian Cancer Recruiting .... Details .... Stage III Ovarian Epithelial Cancer .... Details .... Stage III Ovarian Germ Cell Tumor .... Details .... Stage IV Ovarian Epithelial Cancer .... Details .... Stage IV Ovarian Germ Cell Tumor NCT00741403 NCT00741403 A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies Active, not recruiting .... Details .... Advanced Cancer .... Details .... Metastatic Cancer .... Details .... Lymphoma .... Details .... Solid Tumors .... Details .... Advanced Malignancies NCT00005807 NCT00005807 BMS-247550 in Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer Completed .... Details .... Breast Cancer .... Details .... Ovarian Cancer .... Details .... Unspecified Adult Solid Tumor, Protocol Specific NCT01346579 NCT01346579 Biomarkers in Tissue Samples From Older Women With Breast Cancer Not yet recruiting .... Details .... Breast Cancer NCT01037751 NCT01037751 M. D. Anderson Symptom Inventory - Ovarian Cancer Recruiting .... Details .... Ovarian Cancer NCT01217411 NCT01217411 RO4929097 And Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer Completed .... Details .... Breast Cancer .... Details .... Lung Cancer .... Details .... Melanoma Skin .... Details .... Unspecified Adult Solid Tumor, Protocol Specific NCT00085384 NCT00085384 PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Terminated .... Details .... Fallopian Tube Cancer .... Details .... Ovarian Cancer .... Details .... Peritoneal Cavity Cancer NCT00960427 NCT00960427 Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery Not yet recruiting .... Details .... Colorectal Cancer

powered by ClinicalTrials.gov

powered by www.avvo.com